CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $0 | -100.0% | 246 | -96.2% | 0.00% | – |
Q3 2023 | $6,000 | +50.0% | 6,452 | +99.0% | 0.00% | – |
Q2 2023 | $4,000 | -85.2% | 3,242 | -85.1% | 0.00% | – |
Q1 2023 | $27,000 | – | 21,759 | +144960.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 15 | -99.2% | 0.00% | – |
Q2 2021 | $4,000 | -60.0% | 1,980 | -48.5% | 0.00% | – |
Q1 2021 | $10,000 | +66.7% | 3,846 | +32.3% | 0.00% | – |
Q4 2020 | $6,000 | – | 2,908 | +96833.3% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 614 | +29.5% | 0.00% | – |
Q3 2019 | $1,000 | – | 474 | +1002.3% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 43 | -91.5% | 0.00% | – |
Q1 2017 | $4,000 | -50.0% | 504 | -33.5% | 0.00% | – |
Q4 2016 | $8,000 | +100.0% | 758 | +157.8% | 0.00% | – |
Q3 2015 | $4,000 | -20.0% | 294 | -10.6% | 0.00% | – |
Q2 2015 | $5,000 | – | 329 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,163,631 | $3,095,000 | 1.89% |
5AM Venture Management, LLC | 2,006,511 | $5,337,000 | 0.96% |
INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,609,000 | 0.95% |
Omega Fund Management, LLC | 2,005,249 | $5,334,000 | 0.50% |
KNOTT DAVID M | 415,308 | $1,105,000 | 0.47% |
BVF INC/IL | 3,739,704 | $9,948,000 | 0.37% |
West Family Investments, Inc. | 368,910 | $981,000 | 0.36% |
Monashee Investment Management LLC | 369,099 | $982,000 | 0.15% |
GSA CAPITAL PARTNERS LLP | 178,732 | $475,000 | 0.08% |
JEPPSON WEALTH MANAGEMENT, LLC | 47,550 | $126,000 | 0.08% |